Show Notes
Further evidence for the use of the EarlyCDT Lung blood test in lung cancer screening
Dr Adam M Hill, CEO of Oncimmune, said: "Following last week's announcement of the publication of the ECLS trial in the European Respiratory Journal, we are delighted to see these additional abstracts presented online.
"Beyond proving the ability of the EarlyCDT Lung blood test to detect cancer earlier in a screening population, it is also important to assess the negative impacts of using the test in the population, and the costs of implementing the diagnostic. These findings will no doubt assist our ongoing commercial discussions with health authorities in the UK and in other territories, and we look forward to the peer reviewed publications in due course."
Listen On
Also Listen
-
Ben Turney, Chief Executive Officer of Kavango Resources (LON:KAV) talking to Zaks Traders Cafe
Kavango Resources plc (LSE: KAV), the Southern Africa-focused metals exploratio -
Mosman Oil and Gas (LON:MSMN) CEO Andy Carroll - Progress at EP 145 project, with Govt approval
Andy Carroll, CEO of Mosman Oil and Gas Ltd (LON: MSMN), spoke with Share Talk w -
Zak Mir talks to Bernard Olivier, CEO URA Holdings (LON:URAH) Production Begins at Gravelotte Emerald Mine
In the interview on Zak Mir's channel, Bernard Olivier, CEO of URA Holdings, dis -
Oracle Power (AIM:ORCP) Shareholder Q&A Q1 2024 - Zaks Traders Cafe
Zak Mir talks to Naheed Memon, CEO of Oracle Power, as she answers the latest qu